147 related articles for article (PubMed ID: 36754622)
21. Changes in dentist and dental hygienist numbers in the European Union and economic area.
Widström E; Eaton KA; Luciak-Donsberger C
Int Dent J; 2010 Aug; 60(4):311-6. PubMed ID: 20949764
[TBL] [Abstract][Full Text] [Related]
22. State of the European Union's early notification obligation for drug shortages: enforcement and compliance in eight European countries (2020-2022).
Ravela R; Airaksinen M; Lyles A
J Pharm Policy Pract; 2023 Nov; 16(1):135. PubMed ID: 37936250
[TBL] [Abstract][Full Text] [Related]
23. Shaping EU medicines regulation in the post COVID-19 era.
Cavaleri M; Sweeney F; Gonzalez-Quevedo R; Carr M
Lancet Reg Health Eur; 2021 Oct; 9():100192. PubMed ID: 34661185
[TBL] [Abstract][Full Text] [Related]
24. [The EU Portal: Implementation, importance, and features].
von Aschen H; Krafft H
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 Aug; 60(8):812-816. PubMed ID: 28702715
[TBL] [Abstract][Full Text] [Related]
25. Delays in completion and results reporting of clinical trials under the Paediatric Regulation in the European Union: A cohort study.
Hwang TJ; Tomasi PA; Bourgeois FT
PLoS Med; 2018 Mar; 15(3):e1002520. PubMed ID: 29494592
[TBL] [Abstract][Full Text] [Related]
26. Comparison between European Medicines Agency and US Food and Drug Administration in Granting Accelerated Marketing Authorizations for Covid-19 Medicines and their Utilized Regulations.
Ghadanian M; Schafheutle E
Ther Innov Regul Sci; 2024 Jan; 58(1):79-113. PubMed ID: 37861859
[TBL] [Abstract][Full Text] [Related]
27. The legal framework governing the quality of (traditional) herbal medicinal products in the European Union.
Kroes BH
J Ethnopharmacol; 2014 Dec; 158 Pt B():449-53. PubMed ID: 25086408
[TBL] [Abstract][Full Text] [Related]
28. Catalogue of Communication Tools and Dissemination Guidelines: benchmarking current practice in EU and Member State bodies.
; ; Cantaluppi A; Brasolin D; Folco G; Michi C; Harrington R; Corsini E; Monti S; Nemess J
EFSA J; 2021 Apr; 19(4):e190402. PubMed ID: 33968257
[TBL] [Abstract][Full Text] [Related]
29. Early experience of the European Medical Devices Vigilance System.
Randall H
Australas Phys Eng Sci Med; 1997 Dec; 20(4):203-6. PubMed ID: 9503691
[TBL] [Abstract][Full Text] [Related]
30. Chaos to Clarity: Pragmatic Approaches to Overcome Challenges for Successful Implementation of Additional Risk Minimisation Measures in the European Union and the UK by a Marketing Authorisation Holder.
Hapani K; Parikh N; Pianka K; Patel H
Pharmaceut Med; 2022 Jun; 36(3):173-188. PubMed ID: 35416591
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of mpox contact tracing activities and data collection in EU/EEA countries during the 2022 multicountry outbreak in nonendemic countries.
Prins H; Coyer L; De Angelis S; Bluemel B; Cauchi D; Baka A
J Med Virol; 2024 Jan; 96(1):e29352. PubMed ID: 38180437
[TBL] [Abstract][Full Text] [Related]
32. Results of EAHP's 2019 Medicines Shortages Survey.
Miljković N; Batista A; Polidori P; Kohl S; Horák P
Eur J Hosp Pharm; 2020 Jul; 27(4):202-208. PubMed ID: 32471816
[TBL] [Abstract][Full Text] [Related]
33. Will the EU Clinical Trials Regulation Support the Innovative Industry in Bringing New Medicines Faster to Patients?
Atzor S; Gokhale S; Doherty M
Pharmaceut Med; 2013 Apr; 27(2):75-82. PubMed ID: 23585715
[TBL] [Abstract][Full Text] [Related]
34. Provision of information on regulatory authorities' websites.
Vitry A; Lexchin J; Sasich L; Dupin-Spriet T; Reed T; Bertele V; Garattini S; Toop L; Hurley E
Intern Med J; 2008 Jul; 38(7):559-67. PubMed ID: 18336542
[TBL] [Abstract][Full Text] [Related]
35. Pharmaceutical Regulatory Framework in Ethiopia: A Critical Evaluation of Its Legal Basis and Implementation.
Suleman S; Woliyi A; Woldemichael K; Tushune K; Duchateau L; Degroote A; Vancauwenberghe R; Bracke N; De Spiegeleer B
Ethiop J Health Sci; 2016 May; 26(3):259-76. PubMed ID: 27358547
[TBL] [Abstract][Full Text] [Related]
36. The European Medicines Agency facilitates access to medicines in low- and middle-income countries.
Cavaller Bellaubi M; Harvey Allchurch M; Lagalice C; Saint-Raymond A
Expert Rev Clin Pharmacol; 2020 Mar; 13(3):321-325. PubMed ID: 32053756
[No Abstract] [Full Text] [Related]
37. Access to regulatory data from the European Medicines Agency: the times they are a-changing.
Wieseler B; McGauran N; Kerekes MF; Kaiser T
Syst Rev; 2012 Oct; 1():50. PubMed ID: 23110993
[TBL] [Abstract][Full Text] [Related]
38. The licensing of medicines in the UK.
Drug Ther Bull; 2009 Apr; 47(4):45-8. PubMed ID: 19357299
[TBL] [Abstract][Full Text] [Related]
39. Towards defining core principles of public health emergency preparedness: scoping review and Delphi consultation among European Union country experts.
Belfroid E; Roβkamp D; Fraser G; Swaan C; Timen A
BMC Public Health; 2020 Oct; 20(1):1482. PubMed ID: 32998729
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
